Natixis’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Natixis’s Portfolio HPTX Stock Details HPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-19,700	Closed	-$903K	–	476
2015 Q1	$903K	Buy	+19,700	New	+$589K	0.01%	242

Natixis's HPTX Position: Q2 2015 in Review

Natixis sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 19,700 shares — an estimated $903K sold.

Natixis first reported a position in HPTX in Q1 2015 and held it in 1 quarter. The position peaked at $903K in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

Natixis reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Natixis sold 19,700 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $903K.
Natixis first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q1 2015 and held it in 1 quarter.
Natixis's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $903K in Q1 2015.
0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on Natixis's 13F filing for Q2 2015, filed 14 Aug 2015.